Res. No. 1527 Title Resolution commending Pfizer, Inc. for partnering with the South African Ministry of Health to help combat HIV/AIDS through a drug distribution program. Body By Council Members Clarke, Robles, Freed, Henry, Lopez and Perkins; also Council Members Espada, Fisher, Koslowitz, Leffler, Marshall, Nelson, Povman, Wooten and Abel Whereas, According to the report entitled AIDS in South Africa (the "AIDS report"), issued by the AIDS Foundation of South Africa , it is estimated that 3.6 million South Africans were HIV positive in 1998; and Whereas, The AIDS report found that "one in eight adult South Africans is HIV positive"; and Whereas, Pfizer has had operations in South Africa for over 40 years; and Whereas, According to the AIDS report, Pfizer's anti-HIV efforts in South Africa are more than a decade old; and Whereas, According to the AIDS report, Cryptococcal Meningitis ("CM") is a life-threatening infection of the brain which occurs in approximately 10 percent of AIDS patients; and Whereas, Diflucan, a drug manufactured by Pfizer, has demonstrated its effectiveness in the treatment of CM; and Whereas, The AIDS report states that Pfizer and the South African Ministry of Health are working cooperatively to provide Diflucan to AIDS patients throughout South Africa; and Whereas, Pfizer has promised to provide Diflucan to South African patients, free of charge, for as long as they are undergoing treatment for CM; now, therefore, be it Resolved, That the Council of the City of New York commends Pfizer, Inc. for partnering with the South African Ministry of Health to Combat AIDS/HIV through a drug distribution program. LS#3366 PS:ts 08/15/00 H:resolution una clarke AIDS august 2000 (3)